Nimustine, which was produced by removing Hydrochloride from Nimustine Hydrochloride, was suspended in lipiodol (5mg/ml). The resulting suspension (Nimustine-Lipiodol suspension) was clinically injected to find out the anti-tumor effects on primary carcinoma and metastatic lymph nodes.
[Material and Method]
Nimustine-lipiodol suspension, which has proved to be effective for malignant tumors experimentally, was injected in 22 cases of gastric carcinoma using an endoscope. The movement of the suspension and its effects on primary lesions and metastatic lymph nodes were investigated.
[Result] 1) Movement of injected Nimustine-Lipiodol suspension was investigated by roentgenogram.
(1) Nimustine-Lipiodol suspension, which was injected into the AM area of the stomach, was mainly drained into the lymph nodes around the left gastric artery and right gastroepiploic artery 2 days after injection.
(2) It may be possible to examine the depth of the carcinoma by Nimustine-Lipiodol suspension injected into the circumference of the tumor.
2) Histological examination
(1) In the cases with early gastric carcinoma, Nimustine-Lipiodol suspension was drained into 76.1 ± 18.0% of lymph nodes (N2).
(2) Nimustine-Lipiodol suspension, which was injected into the tumor, was proved to be effective for primary gastric carcinoma in 3 out of 10 cases.
(3) Nimustine-Lipiodol suspension proved to be effective for the metastatic lymph nodes in one case.
[Conclusion] The results obtained in this study may suggest that local injection of Nimustine-Lipiodol suspension can be used as an endoscopic treatment for early gastric carcinoma.
View full abstract